Cole Ikkala is an Investor at Paragon Biosciences, whose known portfolio counts 3 companies.
Is Cole Ikkala a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at Paragon Biosciences, whose known portfolio counts 3 companies
- Castle Creek Biosciences
- Emalex Biosciences
- Evozyne
Investor Profile
Cole Ikkala is listed against sector Healthcare, and focus areas Biotech, Drug Discovery and Pharma in the database.
Stage-wise, the deals at Paragon Biosciences cluster around Growth, Seed and Series B rounds.
What the affiliated firm has backed is the closest available signal on whether Cole Ikkala is worth approaching.
Colleagues at Paragon Biosciences
Frequently asked questions
Who is Cole Ikkala?
Cole Ikkala is an accelerator partner based in Chicago, Illinois, United States, listed as Investor at Paragon Biosciences. The known portfolio of that firm counts 3 companies. That portfolio belongs to the firm, not to Cole Ikkala personally.
What does Cole Ikkala invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Cole Ikkala invest at?
Paragon Biosciences appears in Growth, Seed and Series B rounds across its known deals, and Cole Ikkala is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Cole Ikkala listed at?
Cole Ikkala is listed as Investor at Paragon Biosciences. 3 other people in the database share a firm with Cole Ikkala.
How do I contact Cole Ikkala?
A LinkedIn page is on file for Cole Ikkala. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal